PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common cholesterol drug supercharge TB treatment?
Disease control Recruiting nowThis study tests whether adding the cholesterol-lowering drug atorvastatin to standard TB treatment can help clear the infection faster and improve lung health. About 440 adults and children with new, untreated pulmonary TB will receive either standard care or standard care plus …
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New TB drug could cut treatment time in half for Drug-Resistant patients
Disease control Recruiting nowThis study tests if a new drug, quabodepistat, combined with other TB medicines, can treat drug-resistant tuberculosis (TB) in just 4 months instead of the usual 6 months. About 532 adults and teens with rifampicin-resistant or multidrug-resistant TB will be randomly assigned to …
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Could TB be cured in 8 weeks? major trial launches
Disease control Recruiting nowThis study tests new drug combinations to treat pulmonary tuberculosis (TB) faster than the standard 24-week regimen. About 2,500 adults with TB will receive one of 11 combinations, including two new drugs (BTZ-043 and GSK3036656), for 8 to 16 weeks. The goal is to find a treatme…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
Could a 2-month TB pill replace 6 months of treatment?
Disease control Recruiting nowThis study tests a new ultra-short treatment regimen that works for both drug-sensitive and drug-resistant tuberculosis (TB). The goal is to reduce treatment from the usual 4-6 months down to just 2-3 months, making it simpler and cheaper. About 610 adults with active pulmonary T…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Shenzhen Third People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New TB cocktails aim to speed up recovery
Disease control Recruiting nowThis study tests new combinations of medicines for adults with lung tuberculosis (TB) to see if they work faster and have fewer side effects than the current standard treatment. About 315 participants will receive either a new drug mix or the usual treatment for 8 weeks, then con…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
TB treatment revolution: shorter, stronger drug cocktails on trial
Disease control Recruiting nowThis study tests new combinations of tuberculosis (TB) drugs to see if they work better than the standard treatment. About 390 adults with newly diagnosed, drug-sensitive TB will receive either the usual care or one of several experimental regimens. The goal is to clear the infec…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated May 20, 2026 11:56 UTC